High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$180K
$180,761
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Vivaldi Coelho Rogerio
• Director
10b5-1 SellΔOwn -21.0%
2026-03-12
$161,530
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Director
10b5-1 SellΔOwn -21.0%
|
2026-03-12 | $161,530 | S | Form 4 |
|
CRNX
S
Crinetics Pharmaceuticals, Inc.
Vivaldi Coelho Rogerio
• Director
10b5-1 Sell
2026-03-12
$19,231
|
||||||
| CRNX |
Crinetics Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2026-03-12 | $19,231 | S | Form 4 |